
This research investigates the effectiveness of various biopsy decision support tools that incorporate MRI data to predict clinically significant prostate cancer (csPCa). By assessing calibration, discrimination, and clinical utility, the study underscores the potential of these tools to reduce unnecessary biopsies while maintaining accurate detection rates.
Like
Save
Share